Keith Lundquist, APRN | |
1 Elliot Way Ste 200, Manchester, NH 03103-3502 | |
(603) 663-2315 | |
(603) 647-9180 |
Full Name | Keith Lundquist |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 10 Years |
Location | 1 Elliot Way Ste 200, Manchester, New Hampshire |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407253842 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367H00000X | Anesthesiologist Assistant | 063034-23 (New Hampshire) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Elliot Hospital | Manchester, NH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Amoskeag Anesthesia Pllc | 1759375983 | 93 |
News Archive
Following a benefit assessment in 2016 and an addendum in 2018, the German Institute for Quality and Efficiency in Health Care has again examined biomarker-based tests for women with primary breast cancer.
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that it has extended its contract with Nordion to supply molybdenum-99 (Mo-99) for use in its TechneLite (Technetium Tc 99m Generator) generators. Mo-99 is the parent isotope of technetium-99m (Tc-99m), the medical radioisotope most widely used in nuclear medicine diagnostic imaging tests.
Findings from a new national survey, sponsored by the American Pain Foundation, reveal misperceptions among physicians regarding the misuse and abuse of opioids. The results come in light of government statistics to be released today looking at the broader U.S. population, showing 2009 rates of nonmedical use of these products nationwide.
Our belief as to whether we will likely succeed or fail at a given task-and the consequences of winning or losing-directly affects the levels of neural effort put forth in movement-planning circuits in the human cortex, according to a new brain-imaging study by neuroscientists at the California Institute of Technology.
› Verified 6 days ago
Entity Name | Amoskeag Anesthesia Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104883511 PECOS PAC ID: 1759375983 Enrollment ID: O20040513001385 |
News Archive
Following a benefit assessment in 2016 and an addendum in 2018, the German Institute for Quality and Efficiency in Health Care has again examined biomarker-based tests for women with primary breast cancer.
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that it has extended its contract with Nordion to supply molybdenum-99 (Mo-99) for use in its TechneLite (Technetium Tc 99m Generator) generators. Mo-99 is the parent isotope of technetium-99m (Tc-99m), the medical radioisotope most widely used in nuclear medicine diagnostic imaging tests.
Findings from a new national survey, sponsored by the American Pain Foundation, reveal misperceptions among physicians regarding the misuse and abuse of opioids. The results come in light of government statistics to be released today looking at the broader U.S. population, showing 2009 rates of nonmedical use of these products nationwide.
Our belief as to whether we will likely succeed or fail at a given task-and the consequences of winning or losing-directly affects the levels of neural effort put forth in movement-planning circuits in the human cortex, according to a new brain-imaging study by neuroscientists at the California Institute of Technology.
› Verified 6 days ago
Entity Name | The New London Hospital Association Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831200583 PECOS PAC ID: 5294643623 Enrollment ID: O20040713000500 |
News Archive
Following a benefit assessment in 2016 and an addendum in 2018, the German Institute for Quality and Efficiency in Health Care has again examined biomarker-based tests for women with primary breast cancer.
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that it has extended its contract with Nordion to supply molybdenum-99 (Mo-99) for use in its TechneLite (Technetium Tc 99m Generator) generators. Mo-99 is the parent isotope of technetium-99m (Tc-99m), the medical radioisotope most widely used in nuclear medicine diagnostic imaging tests.
Findings from a new national survey, sponsored by the American Pain Foundation, reveal misperceptions among physicians regarding the misuse and abuse of opioids. The results come in light of government statistics to be released today looking at the broader U.S. population, showing 2009 rates of nonmedical use of these products nationwide.
Our belief as to whether we will likely succeed or fail at a given task-and the consequences of winning or losing-directly affects the levels of neural effort put forth in movement-planning circuits in the human cortex, according to a new brain-imaging study by neuroscientists at the California Institute of Technology.
› Verified 6 days ago
Entity Name | Collaborative Anesthesia Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023522455 PECOS PAC ID: 9133482532 Enrollment ID: O20191011001659 |
News Archive
Following a benefit assessment in 2016 and an addendum in 2018, the German Institute for Quality and Efficiency in Health Care has again examined biomarker-based tests for women with primary breast cancer.
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that it has extended its contract with Nordion to supply molybdenum-99 (Mo-99) for use in its TechneLite (Technetium Tc 99m Generator) generators. Mo-99 is the parent isotope of technetium-99m (Tc-99m), the medical radioisotope most widely used in nuclear medicine diagnostic imaging tests.
Findings from a new national survey, sponsored by the American Pain Foundation, reveal misperceptions among physicians regarding the misuse and abuse of opioids. The results come in light of government statistics to be released today looking at the broader U.S. population, showing 2009 rates of nonmedical use of these products nationwide.
Our belief as to whether we will likely succeed or fail at a given task-and the consequences of winning or losing-directly affects the levels of neural effort put forth in movement-planning circuits in the human cortex, according to a new brain-imaging study by neuroscientists at the California Institute of Technology.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Keith Lundquist, APRN 1 Elliot Way Ste 200, Manchester, NH 03103-3502 Ph: (603) 663-2315 | Keith Lundquist, APRN 1 Elliot Way Ste 200, Manchester, NH 03103-3502 Ph: (603) 663-2315 |
News Archive
Following a benefit assessment in 2016 and an addendum in 2018, the German Institute for Quality and Efficiency in Health Care has again examined biomarker-based tests for women with primary breast cancer.
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that it has extended its contract with Nordion to supply molybdenum-99 (Mo-99) for use in its TechneLite (Technetium Tc 99m Generator) generators. Mo-99 is the parent isotope of technetium-99m (Tc-99m), the medical radioisotope most widely used in nuclear medicine diagnostic imaging tests.
Findings from a new national survey, sponsored by the American Pain Foundation, reveal misperceptions among physicians regarding the misuse and abuse of opioids. The results come in light of government statistics to be released today looking at the broader U.S. population, showing 2009 rates of nonmedical use of these products nationwide.
Our belief as to whether we will likely succeed or fail at a given task-and the consequences of winning or losing-directly affects the levels of neural effort put forth in movement-planning circuits in the human cortex, according to a new brain-imaging study by neuroscientists at the California Institute of Technology.
› Verified 6 days ago